| Followers | 3805 |
| Posts | 244703 |
| Boards Moderated | 0 |
| Alias Born | 07/30/2007 |
Monday, February 04, 2019 1:59:05 PM
"RxAir - The air purifier trusted by hospitals"
Vystar Corp. (OTC Market: VYST) announced today that new and improved RxAir® UV Light Air Purifiers are now available to combat cold, flu and other airborne germs that are more pervasive during the winter. Vystar acquired RxAir approximately nine months ago and immediately began upgrading the air purifiers to improve performance and longevity. The first upgraded RxAir units are now available for purchase via RxAir.com, Rotmans.com, Rotmans Furniture & Carpet in Worcester, Mass., and RxAir medical distributors.
New units now available feature a higher grade UV light bulb that lasts longer and produces longer UV wave length for more efficient killing/inactivation of bacteria, germs and other pathogens. The new units also offer improved alert codes to more easily identify when action, such as replacing a bulb cartridge, is needed.
Hospitals and healthcare facilities have been using industrial size UV light air purification systems for airborne infection control because they have been proven to inactivate a broad array of airborne viruses and bacteria, including influenza and cold viruses.
“Flu vaccines only protect you from a few flu strains and none of them protect you from the common cold and many other illnesses,” stated Bryan Stone, MD, Internal Medicine and Nephrology, Chief of Medicine for Desert Regional Medical Center. “Using UV light to kill airborne germs has been proven as an effective hospital infection control technology for years. The new RxAir now provides an even more effective way to bring this technology into your home or office to reduce your exposure to these pathogens to help avoid infection.”
Dr. Stone discusses how RxAir works in this video.
“As the new owners of RxAir, Vystar is excited to make RxAir available to the public once again — now in a new and improved format — as we enter the peak cold and flu season period,” stated Steve Rotman, Vystar CEO. “We feel it is critical to have a proven germ killing technology that is relied upon by hospitals to be available for purchase online so homes, schools, restaurants, retail stores and medical offices nationwide can reduce the risk of spreading airborne illnesses.”
RxAir is one of the few UV air purifiers that have been proven in independent EPA- and FDA-certified testing laboratories to destroy on first pass more than 99% of harmful viruses and bacteria. In addition to inactivating airborne viruses that cause influenza and colds, RxAir disarms the airborne pathogens that cause MRSA (staph), strep (whooping cough), tuberculosis (TB), measles, pneumonia and a myriad of other antibiotic-resistant and viral infections.
Vystar Corp. (OTC Market: VYST) announced today that new and improved RxAir® UV Light Air Purifiers are now available to combat cold, flu and other airborne germs that are more pervasive during the winter. Vystar acquired RxAir approximately nine months ago and immediately began upgrading the air purifiers to improve performance and longevity. The first upgraded RxAir units are now available for purchase via RxAir.com, Rotmans.com, Rotmans Furniture & Carpet in Worcester, Mass., and RxAir medical distributors.
New units now available feature a higher grade UV light bulb that lasts longer and produces longer UV wave length for more efficient killing/inactivation of bacteria, germs and other pathogens. The new units also offer improved alert codes to more easily identify when action, such as replacing a bulb cartridge, is needed.
Hospitals and healthcare facilities have been using industrial size UV light air purification systems for airborne infection control because they have been proven to inactivate a broad array of airborne viruses and bacteria, including influenza and cold viruses.
“Flu vaccines only protect you from a few flu strains and none of them protect you from the common cold and many other illnesses,” stated Bryan Stone, MD, Internal Medicine and Nephrology, Chief of Medicine for Desert Regional Medical Center. “Using UV light to kill airborne germs has been proven as an effective hospital infection control technology for years. The new RxAir now provides an even more effective way to bring this technology into your home or office to reduce your exposure to these pathogens to help avoid infection.”
Dr. Stone discusses how RxAir works in this video.
“As the new owners of RxAir, Vystar is excited to make RxAir available to the public once again — now in a new and improved format — as we enter the peak cold and flu season period,” stated Steve Rotman, Vystar CEO. “We feel it is critical to have a proven germ killing technology that is relied upon by hospitals to be available for purchase online so homes, schools, restaurants, retail stores and medical offices nationwide can reduce the risk of spreading airborne illnesses.”
RxAir is one of the few UV air purifiers that have been proven in independent EPA- and FDA-certified testing laboratories to destroy on first pass more than 99% of harmful viruses and bacteria. In addition to inactivating airborne viruses that cause influenza and colds, RxAir disarms the airborne pathogens that cause MRSA (staph), strep (whooping cough), tuberculosis (TB), measles, pneumonia and a myriad of other antibiotic-resistant and viral infections.
Recent VYST News
- Vystar and R3alm Launch R3alm.com Following Strategic Transaction • GlobeNewswire Inc. • 04/21/2026 12:00:00 PM
- Vystar Enters into Binding Letter of Intent to Acquire 50% Interest in R3alm Inc. • GlobeNewswire Inc. • 04/20/2026 01:22:43 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 04/15/2026 06:25:19 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/30/2026 03:33:28 PM
- Vystar Announces 2-Week-Long Memorabilia Sweepstakes on X Platform • GlobeNewswire Inc. • 02/18/2026 02:30:00 PM
- Vystar Enters Final Testing of Breakthrough Dialysis Water Filtration Technology • GlobeNewswire Inc. • 01/29/2026 03:40:00 PM
- Vystar to Acquire Stake in GoPaid and Partner with Capital R3alm to Launch R3alm Oracle and Collectibles Platform • GlobeNewswire Inc. • 01/27/2026 03:57:10 PM
- Vystar Corp. Submits Binding Letter of Intent to Acquire Stake in GoPaid.com LLC and Form Strategic Partnership with Capital R3alm to Launch R3alm Oracle and R3alm Collectibles • GlobeNewswire Inc. • 01/08/2026 04:40:38 PM
- Vystar® Reports, Following its First of its Kind Court Victory against EMA Financial, Inc. of $497,439.58 in Legal Fees and Costs Awarded. • GlobeNewswire Inc. • 12/22/2025 08:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/12/2025 05:59:16 PM
- Incubator Stock Review Initiates Coverage on Vystar • GlobeNewswire Inc. • 10/24/2025 02:05:00 PM
- Vystar’s Vytex® Cloud Bed-in-a-Box Available for Sale • GlobeNewswire Inc. • 10/17/2025 12:30:00 PM
- Vystar® to restart sales of Vytex® Cloud Bed-in-a-Box • GlobeNewswire Inc. • 09/12/2025 01:20:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/01/2025 04:16:02 PM
